[{"Assets_0_Q3_USD":164810000.0,"CommonStockSharesOutstanding_0_Q3_shares":25528642.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-112880000.0,"NetIncomeLoss_1_Q3_USD":-18043000.0,"NetIncomeLoss_3_Q3_USD":-100864000.0,"StockholdersEquity_0_Q3_USD":-189838000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]